Live Breaking News & Updates on First Turn Management

Stay updated with breaking news from First turn management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Avoro Capital Advisors LLC Increases Stock Holdings in Ascendis Pharma A/S (NASDAQ:ASND)

Avoro Capital Advisors LLC raised its holdings in Ascendis Pharma A/S (NASDAQ:ASND – Free Report) by 2.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,755,555 shares of the biotechnology company’s stock after buying an additional 85,555 shares during the quarter. Ascendis Pharma A/S […] ....

United States , Ascendis Pharma , Massachusetts Financial Services Co , Westfield Capital Management Co , First Turn Management , Avoro Capital Advisors , Jpmorgan Chase Co , Morgan Stanley , Wells Fargo Company , Cantor Fitzgerald , Free Report , Capital Advisors , Point Capital , Financial Services , Capital Management , Turn Management , Wells Fargo , Get Free Report , Visit Holdingschannel ,

Bellevue Group AG Has $16.70 Million Holdings in Verona Pharma plc (NASDAQ:VRNA)

Bellevue Group AG decreased its position in Verona Pharma plc (NASDAQ:VRNA – Free Report) by 1.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 839,996 shares of the company’s stock after selling 16,362 shares during the period. Bellevue Group AG owned about 1.05% of Verona Pharma […] ....

United States , Verona Pharma , Piper Sandler , Kathleena Rickard , American Century Companies Inc , Hermes Inc , Clearbridge Investments , Eventide Asset Management , Bellevue Group , First Turn Management , Free Report , Turn Management , Asset Management , Century Companies , Get Free Report , Verona Pharma Daily ,

Seven Eight Capital LP Takes Position in Ascendis Pharma A/S (NASDAQ:ASND)

Seven Eight Capital LP purchased a new stake in shares of Ascendis Pharma A/S (NASDAQ:ASND – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 18,636 shares of the biotechnology company’s stock, valued at approximately $2,347,000. A number of […] ....

United States , Stifel Nicolaus , Ascendis Pharma , Westfield Capital Management Co , Exchange Commission , First Turn Management , Ascendis Pharmaas Company Profile , Morgan Stanley , Wells Fargo Company , Massachusetts Financial Services Co , Jpmorgan Chase Co , Seven Eight Capital , Free Report , Point Capital , Financial Services , Capital Management , Turn Management , Get Free Report , Visit Holdingschannel ,

Rhenman & Partners Asset Management AB Has $12.52 Million Stock Position in Cytokinetics, Incorporated (NASDAQ:CYTK)

Rhenman & Partners Asset Management AB lowered its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 25.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 149,912 shares of the biopharmaceutical company’s stock after selling 50,088 shares during the quarter. Rhenman & Partners Asset […] ....

Fady Ibraham Malik , Robert Wong , Raymond James , Cytokinetics Incorporated , Needham Company , First Turn Management , Charles Schwab Investment Management Inc , Norges Bank , Vanguard Group Inc , Securities Exchange Commission , Partners Asset Management , Free Report , Turn Management , Schwab Investment Management , Stock Down , Get Free Report , Ibraham Malik , Cytokinetics Daily ,

Cytokinetics, Incorporated (NASDAQ:CYTK) Shares Bought by Rafferty Asset Management LLC

Rafferty Asset Management LLC lifted its holdings in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 6.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 263,275 shares of the biopharmaceutical company’s stock after purchasing an additional 16,353 shares during the quarter. Rafferty Asset Management LLC’s […] ....

Johnt Henderson , Fady Ibraham Malik , Cytokinetics Company Profile , Norges Bank , Needham Company , Vanguard Group Inc , Charles Schwab Investment Management Inc , Rafferty Asset Management , First Turn Management , Cytokinetics Incorporated , Free Report , Asset Management , Turn Management , Schwab Investment Management , Get Free Report , Director John , Ibraham Malik , Visit Holdingschannel , Cytokinetics Daily ,